Ingenol Mebutate Patent Expiration
Ingenol Mebutate is Used for treating actinic keratosis by inhibiting proliferative activity of neoplastic cells and stimulating the immune system. It was first introduced by Leo Laboratories Ltd
Ingenol Mebutate Patents
Given below is the list of patents protecting Ingenol Mebutate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Picato | US9789078 | Method of topically treating actinic keratosis with ingenol mebutate cycle therapy | May 15, 2033 | Leo Labs |
| Picato | US8278292 | Therapeutic compositions | Jul 06, 2027 | Leo Labs |
| Picato | US8372827 | Therapeutic compositions | Dec 18, 2026 | Leo Labs |
| Picato | US8372828 | Therapeutic compositions | Dec 18, 2026 | Leo Labs |
| Picato | US8377919 | Therapeutic compositions | Dec 18, 2026 | Leo Labs |
| Picato | US8536163 | Therapeutic compositions | Dec 18, 2026 | Leo Labs |
| Picato | US8716271 | Therapeutic compositions | Dec 18, 2026 | Leo Labs |
| Picato | US8735375 | Therapeutic compositions | Dec 18, 2026 | Leo Labs |
| Picato | US9820959 | Therapeutic compositions | Dec 18, 2026 | Leo Labs |
| Picato | US9833428 | Therapeutic compositions | Dec 18, 2026 | Leo Labs |
| Picato | US9833429 | Therapeutic compositions | Dec 18, 2026 | Leo Labs |
| Picato | US9861603 | Therapeutic compositions | Dec 18, 2026 | Leo Labs |
| Picato | US6844013 | Methods of stimulating the immune system |
Dec 13, 2018
(Expired) | Leo Labs |
| Picato | US6432452 | Anti-cancer compounds |
Aug 19, 2018
(Expired) | Leo Labs |
| Picato | US6787161 | Anti-cancer compounds |
Aug 19, 2018
(Expired) | Leo Labs |
| Picato | US7410656 | Anti-cancer compounds |
Aug 19, 2018
(Expired) | Leo Labs |
Ingenol Mebutate's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List